MECP2 and prostate carcinoma: MeCP2 is also involved in cancer through it's binding to the hypermethylated regions of promoters of tumor suppressor genes and thereby cause their subsequent repression in breast cancer (107), prostate cancer (108), lung cancer (109), liver cancer (110), and colorectal cancer (111).